Efficiency of study designs in diagnostic randomized clinical trials

Statistics in Medicine

Volumn 32, Issue 9, 2013, Pages 1451-1466

  Lu, Bo ^a   Gatsonis, Constantine ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Diagnostic randomized clinical trial; Potential outcomes; Sample size; Sensitivity; Specificity

Indexed keywords

ARTICLE; BINOMIAL DISTRIBUTION; BLADDER CANCER; CANCER STAGING; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC RANDOMIZED CLINICAL TRIAL; HUMAN; INTERVENTION STUDY; MATHEMATICAL COMPUTING; PREOPERATIVE PERIOD; RANDOMIZATION; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; STUDY DESIGN; TREATMENT OUTCOME;

COMPUTER SIMULATION; DIAGNOSTIC TESTS, ROUTINE; HUMANS; NEOPLASM STAGING; PROBABILITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE; URINARY BLADDER NEOPLASMS;

EID: 84876306893     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.5655     Document Type: Article

References (20)

1. Zauber A, Lansdorp-Vogelaar I, Knudsen A, Wilschut J, van Ballegooijen M, Kuntz K. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. preventive services task force. Annals of Internal Medicine 2008; 149:659-669.
2. Bossuyt P, Lijmer J, Mol B. Randomised comparison of medical tests: sometimes invalid, not always efficient. Lancet 2000; 356:1844-1847.
3. Lijmer JG, Bossuyt PM. Diagnostic testing and prognosis: the randomised controlled trial in diagnostic research. In The Evidence Base of Clinical Diagnosis, Knottnerus JA (ed.). BMJ Books: London, 2002.
4. de Graaff JC, Ubbink DT, Tijssen JGP, Legemate DA. The diagnostic randomised clinical trial is the best solution for management issues in critical limb ischemia. Journal of Clinical Epidemiology 2004; 57:1111-1118.
5. Sargent D, Conley B, Allegra C, Collette L. Clinical trial design for predictive marker validation in cancer treatment trials. Journal of Clinical Oncology 2005; 23:2020-2027.
6. Vickers A, Jang K, Sargent D, Lilja H, Kattan M. (2008) Systematic review of statistical methods used in molecular marker studies in cancer. Cancer 2008; 112:1862-1868.
7. Bogaerts J, Cardoso F, Buyse M, Braga S, Loi S, Harrison JA, Bines J, Mook S, Decker N, Ravdin P, Therasse P, Rutgers E, van 't Veer LJ, Piccart M, TRANSBIG consortium. Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial. Nature Clinical Practice Oncology 2006; 3:540-551.
8. Rutgers E, Piccart-Gebhart MJ, Bogaerts J, Delaloge S, Veer LV, Rubio IT, Viale G, Thompson AM, Passalacqua R, Nitz U, Vindevoghel A, Pierga JY, Ravdin PM, Werutsky G, Cardoso F. The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phase. European Journal of Cancer 2011; 47:2742-2749.
9. Meiner CL. Clinical Trials: Design, Conduct, and Analysis. Oxford University Press: New York, 1986.
10. Neyman J. On the application of probability theory to agricultural experiments. Essay on principles. Section 9, translated in Statistical Science 1923; 5:465-480.
11. Rubin D. Estimating causal effects of treatment in randomized and nonrandomized studies. Journal of Educational Psychology 1974; 66:688-701.
12. Lord SJ, Irwig L, Bossuyt P. Using the principles of randomized controlled trial design to guide test evaluation. Medical Decision Making 2009; 29:E1-E12.
13. Lijmer J, Bossuyt P. Various randomized designs can be used to evaluate medical tests. Journal of Clinical Epidemiology 2009; 62:364-373.
14. di Ruffano LF, Hyde CJ, McCafferyv KJ, Bossuyt P, Deeks JJ. Assessing the value of diagnostic tests: a framework for designing and evaluating trials. British Medical Journal 2012; 344:e686.
15. de Graaff JC, Ubbink DT, Legemae DA, Tijssen JG, Jacobs MJ. Evaluation of toe pressure and transcutaneous oxygen measurements in management of chronic critical leg ischemia: a diagnostic randomized clinical trial. Journal of Vascular Surgery 2003; 38:528-534.
16. Winquist E, Kirchner TS, Segal R, Chin J, Lukka H. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis. Journal of Urology 2004; 171:561-569.
17. Patel A, Campbell S. Current trend in the management of bladder cancer. Journal of Wound, Ostomy and Continence Nursing 2009; 36:413-421.
18. Deserno W, Harisinghani M, Taupitz M, Jager G, Witjes JA, Mulders P, Hulsbergen van de Kaa J, Kaufman D, Barentsz J. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 2004; 233:449-456.
19. Drieskens O, Oyen R, Van Poppel H, Vankan Y, Flamen P, Mortelmans L. FDG-PET for preoperative staging of bladder cancer. European Journal of Nuclear Medicine and Molecular Imaging 2005; 32:1412-1417.
20. Leissner J, Hohenfellner R, Thuroff JW, Wolf HK. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. Brithish Journal of Urology International 2000; 85:817-23.